Jove
Visualize
Contact Us

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

393
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
393
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

820
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
820
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

911
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
911
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

608
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
608
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

4.0K
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
4.0K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

641
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
641

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maralixibat for PFIC.

Canadian liver journal·2026
Same author

Five public health measures to improve the liver health of Canadians.

Canadian liver journal·2026
Same author

A hepatology hero rides off into the sunset: A tribute to Dr Gerald Minuk.

Canadian liver journal·2026
Same author

The emerging role of liver transplantation in metastatic colorectal cancer.

Canadian liver journal·2025
Same author

Coffee: nature's remedy for liver disease.

Canadian liver journal·2025
Same author

Are we doing enough to detect alcohol use disorder? The case for accessible AST testing in Canada.

Canadian liver journal·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 18, 2026

Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery
04:03

Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery

Published on: March 28, 2025

554

Primary sclerosing cholangitis: diagnostic and management challenges.

Sanjeev Sirpal1, Natasha Chandok2

  • 1Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), University of Montreal, Montreal, QC.

Clinical and Experimental Gastroenterology
|November 16, 2017
PubMed
Summary

Primary sclerosing cholangitis (PSC) is a rare immune disease of the bile ducts. Current treatments are limited, highlighting the need for new therapies for this challenging condition.

Keywords:
PSCmanagementprimary sclerosing cholangitis

Related Experiment Videos

Last Updated: Feb 18, 2026

Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery
04:03

Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery

Published on: March 28, 2025

554

Area of Science:

  • Hepatology
  • Immunology
  • Gastroenterology

Background:

  • Primary sclerosing cholangitis (PSC) is a chronic, immune-mediated cholestatic liver disease.
  • It primarily affects intra- and extrahepatic bile ducts, often leading to cirrhosis and cholangiocarcinoma.
  • PSC is strongly associated with inflammatory bowel disease, predominantly affecting middle-aged males.

Purpose of the Study:

  • To review the diagnostic and management challenges of PSC.
  • To analyze current therapeutic options and their limitations.
  • To provide insights into future treatment strategies for PSC.

Main Methods:

  • Literature review of diagnostic criteria for PSC.
  • Analysis of existing medical and surgical treatments for PSC.
  • Discussion of emerging therapeutic targets and future research directions.

Main Results:

  • PSC presents with a wide spectrum of clinical manifestations, from asymptomatic cholestasis to end-stage liver disease.
  • Current treatments for PSC are largely supportive, with liver transplantation being the only curative option for advanced disease.
  • There is a significant unmet need for effective disease-modifying therapies.

Conclusions:

  • PSC poses considerable diagnostic and management challenges due to its complexity and rarity.
  • Existing therapies for PSC are limited in efficacy and scope.
  • Future research should focus on developing targeted therapies to address the underlying immune mechanisms of PSC.